Differences

This shows you the differences between two versions of the page.

--- content:alpha-feto_protein_serum [2020/02/16 20:53] – icna
+++ content:alpha-feto_protein_serum [2020/02/16 20:54] – icna
@@ Line 8: / Line 8: @@
 Increased serum AFP is a biomarker for [[Ataxia Telangiectasia]], [[ataxia-oculomotor apraxia 2]] (AOA2), [[Deoxyguanosine Kinase Deficiency]](DGUOK) deficiency (hepatocerebral form of mtDNA depletion). Measurement of serum AFP is very useful in the diagnostic workup of [[autosomal recessive cerebellar ataxias]] (ARCAs).
-CSF AFP levels in normal infants also decline with gestational age in proportion to levels of AFP in serum[(:cite:PMID10612715>{{pubmed>short:10612715}})][(:cite:15802029>{{pubmed>short:15802029}})].
-  * median 61 kIU/L (5th-95th centile: 2-889 kIU/L) in infants -69 to 31 days old
-  * median 1.2 kIU/L (5th-95th centile: 0.1-12.5 kIU/L) in infants 32 to 110 days old
   * **Classic Ataxia Telangiectasia**
@@ Line 36: / Line 32: @@
     * raised serum/csf lactate
-==== References ====
+CSF AFP levels in normal infants also decline with gestational age in proportion to levels of AFP in serum[(:cite:PMID10612715>{{pubmed>short:10612715}})][(:cite:15802029>{{pubmed>short:15802029}})].
-~~REFNOTES~~
+  * median 61 kIU/L (5th-95th centile: 2-889 kIU/L) in infants -69 to 31 days old
+  * median 1.2 kIU/L (5th-95th centile: 0.1-12.5 kIU/L) in infants 32 to 110 days old